Sign In
to Vote &
Create Storyboards.
 

Bristol-Myers Has Farther to Fall

Wall Street Journal - 16 Apr 2018 22:07
Bristol-Myers Squibb shareholders have a valuation problem after releasing mixed clinical data in a carefully watched trial for patients with lung cancer.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard